English

cancer-patients / English

Stories published on Oct 13
  • Related stories in the last 90 days
  • Stories published on Oct 13

Monday, Oct 13

00

Is UK National Screening Committee really going to deny prostate tests for sake of £18 a patient? Report estimates targeted screening would save thousands of men's lives

www.dailymail.co.uk

A lifesaving prostate screening programme would require only five more MRI scanners and 75 extra staff, including four urologists, Prostate Cancer Research says.

23

Radiation-Free Approach Promising for Some Locally Advanced Lung Cancers

www.medpagetoday.com

(MedPage Today) -- In a small phase II trial, radiation-free treatment with pembrolizumab (Keytruda) and platinum-based chemotherapy alone proved promising for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC)…

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

www.benzinga.com

"The Phase 1 results and Cyclin E1 biomarker findings accepted for presentation at AACR-NCI-EORTC reinforce our biomarker-driven strategy for azenosertib in Cyclin E1-positive platinum-resistant ovarian cancer patients, an underserved…

20

Bioengineering breathes new life into failed cancer treatment

medicalxpress.com

Many advanced cancers develop resistance to treatment and become highly aggressive, often leaving patients with limited treatment options. In some cancers, including lung, pancreatic and prostate tumors, a key driver of treatment…

19

Remix Therapeutics to Present Phase 1 Data of REM-422 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Conference in Late-Breaking Oral Presentation

www.benzinga.com

The presentation will highlight results from the ongoing Phase I trial's primary objectives of defining safety, dose-limiting toxicities, and a recommended phase 2 dose (RP2D). Secondary objectives include evaluating preliminary antitumor…

Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations

www.benzinga.com

Taiho Oncology Inc. and Cullinan Therapeutics Inc. (NASDAQ:CGEM) shared new data on Sunday from the central nervous system (CNS) involvement cohort of the REZILIENT2 study of zipalertinib for advanced or metastatic non-small cell lung…

18

Cancer Patient Approached by Stranger at the Mall—What She Says Goes Viral

www.newsweek.com

"I mean, it was obvious, but I was still surprised by her question," Lauren O'Connell told Newsweek.

Russian cancer patients face scan shortages amid Western sanctions

www.rt.com

Cancer patients in Russia’s Far East are losing access to vital PET scans due to Western sanctions halting radiopharmaceutical supplies Read Full Article at RT.com

17

Gilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 Months

www.benzinga.com

On Sunday, Arcus Biosciences Inc. (NYSE:RCUS) announced the first overall survival results from Arm A1 of the Phase 2 EDGE-Gastric study in patients with locally advanced, unresectable, or metastatic gastric, gastroesophageal junction, or…

16

General Oncology to Present Preliminary Phase 1 Results from SHARON Trial in Patients with BRCA/PALB2-mutated Pancreatic and Breast Cancer at ESMO 2025

www.benzinga.com

BOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc. ("General Oncology" or the "Company"), a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced…

14

'Deeply unfair': Anger as breast cancer patients in Scotland denied 'promising' drug approved by NHS England

www.scotsman.com

A drug that has been approved for use by the NHS in England has been rejected in Scotland

12

Study opens up possibility of bespoke prostate cancer treatment

medicalxpress.com

A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive to radiation in specific parts of the rectum than others. The knowledge could reduce the risk of severe bowel…

Study opens up possibility of bespoke prostate cancer treatment

www.manchester.ac.uk

A groundbreaking study led by University of Manchester scientists has identified genetic variants which make some patients more sensitive to radiation in specific parts of the rectum than others.

02

Advanced genetic tests could predict patients at risk of blood cancer relapse

www.standard.co.uk

It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.

Advanced genetic tests could predict patients at risk of blood cancer relapse

www.expressandstar.com

It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.

Advanced genetic tests could predict patients at risk of blood cancer relapse

www.shropshirestar.com

It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.

Sunday, Oct 12

14

Saturday, Oct 11

10

'I've got breast cancer and have been left to die in prison miles from hospital'

www.mirror.co.uk

Cancer patient Farah Damji believes she has been "ghosted" to HMP Eastwood Park after becoming an "irritant" to prison leaders at HMP Bronzefield where she spoke up for other female prisoners

04

Astros’ Hall of Famer and His Wife Escort a Young Cancer Patient Down the Runway In an Emotional Catwalk Celebration

www.papercitymag.com

Social celebrities might come and go, but Major League Baseball Hall of Famers live on, we could say, forever. So it was with special excitement that Hall of Famer Jeff Bagwell and his wife Rachel Bagwell signed on once again to escort a…